| Kwality Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 539997 |
NSE Symbol : - |
P/E(TTM) : 18.93 |
|
ISIN Demat : INE552U01010 |
Div & Yield% : 0.00 |
EPS(TTM) : 47.31 |
|
Book Value(₹) : 280.56 |
Market Cap(₹Cr) : 929.40 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 111.31 | 111.48 | 115.68 | 84.41 | 90.03 | 80.08 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 111.31 | 111.48 | 115.68 | 84.41 | 90.03 | 80.08 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.90 | 0.38 | 0.77 | 0.65 | 0.22 | 0.28 |
| Total Income | 112.21 | 111.85 | 116.44 | 85.06 | 90.26 | 80.36 |
| Total Expenditure | 85.96 | 87.29 | 89.78 | 66.90 | 70.35 | 62.72 |
| PBIDT | 26.25 | 24.56 | 26.66 | 18.16 | 19.90 | 17.63 |
| Interest | 2.84 | 2.76 | 2.49 | 2.20 | 2.71 | 2.48 |
| PBDT | 23.41 | 21.80 | 24.17 | 15.96 | 17.20 | 15.16 |
| Depreciation | 4.96 | 4.76 | 5.08 | 4.55 | 4.61 | 4.02 |
| Tax | 4.15 | 4.36 | 6.18 | 2.87 | 4.07 | 2.80 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.18 | 0.75 | -1.59 | 0.00 | 0.03 | -0.03 |
| Reported Profit After Tax | 14.12 | 11.93 | 14.50 | 8.54 | 8.49 | 8.37 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 14.12 | 11.93 | 14.50 | 8.54 | 8.49 | 8.37 |
| EPS (Unit Curr.) | 13.60 | 11.50 | 13.97 | 8.23 | 8.18 | 8.06 |
| EPS (Adj) (Unit Curr.) | 13.60 | 11.50 | 13.97 | 8.23 | 8.18 | 8.06 |
| Calculated EPS (Unit Curr.) | 13.60 | 11.50 | 13.97 | 8.23 | 8.18 | 8.06 |
| Calculated EPS (Adj) (Unit Curr.) | 13.60 | 11.50 | 13.97 | 8.23 | 8.18 | 8.06 |
| Calculated EPS (Ann.) (Unit Curr.) | 54.42 | 46.00 | 55.89 | 32.92 | 32.71 | 32.25 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 54.42 | 46.00 | 55.89 | 32.92 | 32.71 | 32.25 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 23.58 | 22.03 | 23.05 | 21.51 | 22.10 | 22.02 |
| PBDTM(%) | 21.03 | 19.56 | 20.89 | 18.91 | 19.10 | 18.93 |
| PATM(%) | 12.69 | 10.70 | 12.53 | 10.12 | 9.43 | 10.45 |